Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine

Chemico-Biological Interactions

Volumn 181, Issue 1, 2009, Pages 15-19

  Wan, Xu ying ^a   Luo, Ming ^a   Li, Xiao dong ^a   He, Ping ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Anti hepatocarcinogenic effect; Anti inflammatory effect; Glycyrrhizin; Hepatoprotective activity; Immunoregulation; Matrine

Indexed keywords

ALBUMIN; DIETHYLNITROSAMINE; GLUTATHIONE; GLYCYRRHIZIC ACID; MATRINE; PARACETAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; DRUG POTENTIATION; INCIDENCE; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER PROTECTION; LIVER TOXICITY; NONHUMAN; PAW EDEMA; RAT; SODIUM RETENTION; WATER RETENTION;

ACETAMINOPHEN; ALKALOIDS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHLORIDES; CYCLOPHOSPHAMIDE; DIETHYLNITROSAMINE; GLUTATHIONE; GLYCYRRHIZIC ACID; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED ICR; POTASSIUM; QUINOLIZINES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SODIUM;

GLYCYRRHIZA; GLYCYRRHIZA GLABRA; MUS; RATTUS; SOPHORA FLAVESCENS;

EID: 67650651929     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.04.013     Document Type: Article

References (38)

1. Seeff L.B., Lindsay K.L., Bacon B.R., Kresina T.F., and Hoofnagle J.H. Hepatology 34 (2001) 595-603
2. Lin W., Zhang J.P., Hu Z.L., et al. Inhibitory effect of Mat on lipopolysaccharide induced tumor necrosis factor and interleukin-6 production from rat Kupfer cells. Acta Pharm. Sin. 32 (1997) 93-96
3. Liang P., Bo A.H., and Xue G.P. Study on the mechanism of Mat on immune liver injury in rats. World Chin. J. Digest 7 (1999) 104-108 (Chinese)
4. Zhang J.P., Zhang M., Zhou J.P., et al. Antifibrotic effects of Mat on in vitro and in vivo models of liver fibrosis in rats. Acta Pharmacol. Sin. 22 (2001) 183-186
5. Ai J., Gao H.H., He S.Z., et al. Effects of Mat, artemisinin, and let randrine on cytosolic in guinea pig ventricular myocytes. Acta Pharmacol. Sin. 22 (2001) 512-515
6. Ma L., Wen S., Zhan Y., et al. Anticancer effects of the Chinese medicine Mat on murine hepatocellular carcinoma cells. Planta. Med. 74 (2008) 245-251
7. Shen X.D., Song G.B., Yan R.B., et al. Research progress of Mat and oxymatirne in the anti-tumor mechanism. J. Chongqing Univ. (Natural Science Edition) 28 (2005) 125-128
8. Tao S.C., and Wang J.Z. The pharmacological function of Mat. Acta Pharmacol. Sin. 27 (1992) 201
9. Long Y., Lin X.T., Zeng K.L., et al. Efficacy of intramuscular Mat in the treatment of chronic hepatitis B. Hepatobiliary Pancreat. Dis. Int. 3 (2004) 69-72
10. Zhu X.H., Qiu Y.D., and Shi M.K. Effect of Mat on cold ischemia and reperfusion injury of sinusoidal endothelial cells in rat orthotropic liver transplantation. Acta Pharmacol. Sin. 24 (2003) 169-174
11. Isbrucker R.A., and Burdock G.A. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of Gly. Regul. Toxicol. Pharmacol. 46 (2006) 167-192
12. Kurisu S., Inoue I., Kawagoe T., et al. Clinical profile of patients with symptomatic Gly-induced hypokalemia. J. Am. Geriatr. Soc. 56 (2008) 1579-1581
13. Bing L., and Yun Q. The pharmacology research progression of Gly acid and glycyrrhetic acid, foreign medicine. Planta. Med. 21 (2006) 100-104
14. Kimura M., Moro T., and Motegi H. In vivo Gly accelerates liver regeneration and rapidly lowers serum transaminase activities in 70% partially hepatectomized rats. Eur. J. Pharmacol. 579 (2008) 357-364
15. WenYa L., and HanQing L. The pharmacology research progression of the Sophora flavescens base. Chin. J. Pract. Chin. Modern Med. 19 (2006) 473-475
16. Asl M.N., and Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res. 22 (2008) 709-724
17. Ray S.D., Mumaw V.R., Raje R.R., and Fariss M.W. Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinole pretreatment. J. Pharmacol. Exp. Ther. 279 (1996) 1470-1483
18. Kon K., Kim J.S., Jaeschke H., and Lemasters J.J. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology 40 (2004) 1170-1179
19. Jaeschke H., and Bajt M.L. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol. Sci. 89 (2006) 31-41
20. Terneus M.V., Kiningham K.K., Carpenter A.B., Sullivan S.B., and Valentovic M.A. Comparison of S-adenosyl-l-methionine and N-acetylcysteine protective effects on acetaminophen hepatic toxicity. J. Pharmacol. Exp. Ther. 320 (2007) 99-107
21. Deneke S.M., and Fanburg B.L. Regulation of cellular glutathione. Am. J. Physiol. 257 (1989) 163-173
22. Anderson C.P., Tsai J.M., Meek W.E., et al. Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cells lines via apoptosis. Exp. Cell Res. 246 (1999) 183-192
23. Mirochnitchenko O., Weisbrot-Lefkowitz M., Reuhl K., Chen L., Yang C., and Inouye M. Acetominophen toxicity: opposite effects of two forms of glutathione peroxidase. J. Biol. Chem. 274 (1999) 10349-10355
24. Lee W.M. Acetaminophen toxicity: changing perceptions on a social/medical issue. Hepatology 46 (2007) 966-970
25. Gumpricht E., Dahl R., Devereaux M.W., and Sokol R.J. Licorice compounds Gly and 18beta-glycyrrhetinic acid are potent modulators of bile acid-induced cytotoxicity in rat hepatocytes. J. Biol. Chem. 280 (2005) 10556-10563
26. Jeong H.G., You H.J., Park S.J., et al. Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression. Pharmacol. Res. 46 (2002) 221-227
27. Yin J., Li D.H., Hu M.W., and Meng Q. Effects of glycyrrhizic acid on cocklebur induced hepatotoxicity in rat and human hepatocytes. Phytother. Res. 22 (2008) 395-400
28. Zhai D., Zhao Y., Chen X., Guo J., He H., Yu Q., Yang J., Davey A.K., and Wang J. Protective effect of Gly, glycyrrhetic acid and Mat on acute cholestasis induced by alpha-naphthyl isothiocyanate in rats. Planta. Med. 73 (2007) 128-133
29. Zhao Y., Zhai D., Chen X., He H., Lu Q., and Yu Q. Protective effect of Gly and Mat on acute vanishing bile duct syndrome induced by alpha-naphthylisothiocyanate in rats. Hepatol. Res. 37 (2007) 143-151
30. Lee C.H., Park S.W., Kim Y.S., Kang S.S., Kim J.A., Lee S.H., and Lee S.M. Protective mechanism of Gly on acute liver injury induced by carbon tetrachloride in mice. Biol. Pharm. Bull. 30 (2007) 1898-1904
31. Chakraborty T., Chatterjee A., Rana A., Dhachinamoorthi D., Kumar P.A., and Chatterjee M. Carcinogen-induced early molecular events and its implication in the initiation of chemical hepatocarcinogenesis in rats: chemopreventive role of vanadium on this process. Biochim. Biophys. Acta 1772 (2007) 48-59
32. Peto R., Gary R., Brantom P., and Grasso P. Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosomethylamine. Cancer Res. 51 (1991) 6452-6469
33. Lee J.S., Chu I.S., Mikaelyan A., Calvisi D.F., Heo J., Reddy J.K., and Thorgeirsson S.S. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat. Genet. 36 (2004) 1306-1311
34. Toledo L.P., Ong T.P., Pinho A.L.G., Jordao Jr. A.A., Vanucchi H., and Moreno F.S. Inhibitory effects of lutein and lycopene on placental glutathione S-transferase positive preneoplastic lesions and DNA strand breakage induced in Wistar rats by the resistant hepatocyte model of hepatocarcinogenesis. Nutr. Cancer 47 (2003) 62-69
35. Ma L.D., Zhang Y., Wen S.H., et al. Inhibition of tumor growth in tumor-bearing mice treated with Mat. Zhonghua Zhong Liu Za Zhi 27 (2005) 339-341
36. Zhaowu Z., Xiaoli W., Yangde Z., and Nianfeng L. Preparation of Mat ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats. J. Liposome Res. 24 (2009) 1-8
37. Guo A.X., Huang X.G., and Le L.M. Immunological functions affected by Mat in immunocompromised mice. Chin. J. Mod. Drug 2 (2008) 7-9
38. Hou F.X., Yang H.F., Yu T., and Chen W. The immunosuppressive effects of 10 mg/kg cyclophosphamide in Wistar rats. Environ. Toxicol. Pharmacol. 24 (2007) 30-36